Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial

This randomized controlled trial evaluated clinical durability of Zilver PTX, a paclitaxel-coated drug-eluting stent (DES), for femoropopliteal artery lesions. Outcomes compare primary DES versus percutaneous transluminal angioplasty (PTA), overall DES (primary and provisional) versus standard care...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Circulation (New York, N.Y.) Ročník 133; číslo 15; s. 1472 - 83; discussion 1483
Hlavní autori:	Dake, Michael D, Ansel, Gary M, Jaff, Michael R, Ohki, Takao, Saxon, Richard R, Smouse, H Bob, Machan, Lindsay S, Snyder, Scott A, O'Leary, Erin E, Ragheb, Anthony O, Zeller, Thomas
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 12.04.2016
Predmet:	Adult Aged Angioplasty Anticoagulants - therapeutic use Arterial Occlusive Diseases - drug therapy Arterial Occlusive Diseases - therapy Aspirin - therapeutic use Clopidogrel Combined Modality Therapy Disease Progression Disease-Free Survival Drug-Eluting Stents Equipment Failure Female Femoral Artery - drug effects Follow-Up Studies Humans Intermittent Claudication - therapy Ischemia - surgery Ischemia - therapy Male Middle Aged Paclitaxel - administration & dosage Paclitaxel - therapeutic use Popliteal Artery - drug effects Recurrence Stents Ticlopidine - analogs & derivatives Ticlopidine - therapeutic use Vascular Patency paclitaxel drug-eluting stents peripheral artery disease stents angioplasty
ISSN:	1524-4539
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!